Skip to main content
. 2023 Jul 29;9(8):e18443. doi: 10.1016/j.heliyon.2023.e18443

Fig. 1.

Fig. 1

Concentration-time profiles of RD2 in plasma and CSF following single (A) 3 mg/kg i.v., (B) 20 mg/kg p.o. and (C) 50 mg/kg p.o. administration of RD2 to young dogs (1.7–1.8 years of age). Data are presented as mean; n = 6.